Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer

International Journal of Radiation Biology

Volumn 87, Issue 1, 2011, Pages 46-56

  Werbrouck, Joke ^a   Duprez, Fréderic ^b   De Neve, Wilfried ^b   Thierens, Hubert ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

H2AX foci; acute normal tissue complications; DNA DSB repair; head and neck cancer; radiosensitivity assay

Indexed keywords

CISPLATIN DERIVATIVE; DOUBLE STRANDED DNA; GAMMA HISTONE H2AX; HISTONE H2AX; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; CANCER PATIENT; CANCER RADIOTHERAPY; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DYSPHAGIA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; INTENSITY MODULATED RADIATION THERAPY; LYMPHOBLASTOID CELL; LYMPHOCYTE; MALE; MICROSCOPY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION DERMATITIS; RADIATION DOSE; RADIATION SICKNESS; RISK ASSESSMENT; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; FEMALE; GAMMA RAYS; HEAD AND NECK NEOPLASMS; HISTONES; HUMANS; KINETICS; LYMPHOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY, INTENSITY-MODULATED;

ATAXIA TELANGIECTASIA;

EID: 78650122325     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2010.518213     Document Type: Article

References (50)

1. Andrievski A, Wilkins RC. 2009. The response of g-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures. International Journal of Radiation Biology 85:369-376.
2. Antonelli F, Belli M, Cuttone G, Dini V, Esposito G, Simone G, Sorrentino E, Tabocchini A. 2005. Induction and repair of DNA double-strand breaks in human cells: Dephosphorylation of histone H2AX and its inhibition by Cacyculin A. Radiation Research 164:514-517. (Pubitemid 41368928)
3. Banáth JP, MacPhail SH, Olive PL. 2004. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Research 64:7144-7149. (Pubitemid 39331029)
4. Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, Monroe BC, Ciccone DN, Yan C, Vlasakova K, Livingston DM, Ferguson DO, Scully R, Alt FW. 2002. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proceedings of the National Academy of Sciences of the USA 99:8173-8178. (Pubitemid 34651025)
5. Bourguignon MH, Gisone PA, Perez MR, Michelins S, Dubner D, Giorgio MD, Carosella ED. 2005. Genetic and epigenetic features in radiation sensitivity. Part II: Implications for clinical practice and radiation protection. European Journal of Nuclear Medicine and Molecular Imaging 32:351-368. (Pubitemid 40562128)
6. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A. 2003. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nature Cell Biology 5:675-679. (Pubitemid 36818091)
7. Chun HH, Gatti RA. 2004. Ataxia-telangiectasia, an evolving phenotype. DNA Repair 3:1187-1196. (Pubitemid 38997962)
8. Corvò R. 2007. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiotherapy and Oncology 85:156-170. (Pubitemid 47562578)
9. De Neve W. 2006. Rationale of intensity modulated radiation therapy: A clinician's point of view. In: Bortfeld T, Schmidt- Ullrich R, De Neve W, Wazer DE, editors. Image-guided IMRT. Berlin: Springer-Verlag. pp 3-9.
10. Ding M, Newman F, Raben D. 2005. New radiation therapy techniques for the treatment of head and neck cancer. Otolaryngologic Clinics of North America 38:371-395.
11. Dirix P, Nuyts S. 2010. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncology 11:985-991.
12. Duprez F, Bonte K, De Neve W, Boterberg T, De Gersem W, Mandani I. 2010. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer. International Journal of Radiation Oncology Biology Physics. (in press).
13. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, Marsh R, Pameijer FA, Balm AJM. 2004. Dysphagia and aspiration after chemotherapy for head and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? International Journal of Radiation Oncology Biology Physics 60:1425-1439. (Pubitemid 39601860)
14. FitzGerald MD, Bean JM, Hedge SR, Unsal H, MacDonald DJ, Harkin DP. 1997. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genetics 15:307-310. (Pubitemid 27098729)
15. Giro C, Berger V, Bö lke E, Ciernik F, Duprez F, Locati L, Maillard S, Ozsahin M, Pfeffer R, Robertson AG, Langendijk JA, Budach W. 2009. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes. Radiotherapy and Oncology 90:166-171.
16. Hymes SR, Strom EA, Fife C. 2006. Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006. Journal of the American Academy of Dermatology 54:28-46. (Pubitemid 41832455)
17. Kato TA, Nagasawa H, Weil MM, Little JB, Bedford JS. 2006. Levels of g-H2AX foci after low-dose-rate irradiation reveal a DNA DSB rejoining defect in cells from human ATM heterozygotes in two AT families and in another apparently normal individual. Radiation Research 166:443-453. (Pubitemid 44353427)
18. Klokov D, MacPhail SM, Banáth JP, Byrne JP, Olive PL. 2006. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiotherapy and Oncology 80:223-229. (Pubitemid 44301540)
19. Kühne M, Riballo E, Rief N, Rothkamm K, Jeggo PA, Löbrich M. 2004. A double strand break repair defect in ATMdeficient cells contributes to radiosensitivity. Cancer Research 64:500-508. (Pubitemid 38120888)
20. Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJM, Kolkman Deurloo I, Prevost J, Poll J, Schmitz PIM, Heijmen BJ. 2007. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiotherapy and Oncology 85:64-73. (Pubitemid 47562584)
21. Lö brich M, Rief N, Kü hne M, Heckmann M, Fleckenstein J, Rübe C, Uder M. 2005. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proceedings of the National Academy of Sciences of the USA 102:8984-8989. (Pubitemid 40881065)
22. MacPhail SH, Banáth JP, Yu TY, Chu EHM, Lambur H, Olive PL. 2003. Expression of hosphorylated histone H2AX in cultured cell lines following exposure to X-rays. International Journal of Radiation Biology 79:351-358. (Pubitemid 36920536)
23. Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M, Jacobs F, Grégoire V, Lonneux M, Vakaet L, Vanderstraeten B, Bauters W, Bonte K, Thierens H, De Neve W. 2007. Positron emission tomography-guided, focal-dose escalation using intensity modulated radiotherapy for head and neck cancer. International Journal of Radiation Oncology Biology Physics 68:126-135. (Pubitemid 46589860)
24. Mahrhofer HM, Bü rger S, Oppitz U, Flentje M, Djuzenova CS. 2006. Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation. International Journal of Radiation Oncology Biology Physics 64:573-580. (Pubitemid 43083447)
25. Menegakis A, Yaromina A, Eicheler W, Dörfler A, Beuthien- Baumann B, Thames HD, Baumann M, Krause M. 2009. Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gH2AX staining. International Journal of Radiation Biology 85:1032-1041.
26. Murphy BA, Gilbert J. 2009. Dysphagia in head and neck cancer patients treated with radiation: Assessment, sequelae and rehabilitation. Seminars in Radiation Oncology 19:35-42.
27. Murphy BA, Gilbert J, Cmelak A, Ridner SH. 2007. Symptom control issues and supportive care for patients with head and neck cancers. Clinical Advances in Hematology and Oncology 5:807-822. (Pubitemid 351715490)
28. Olive PL, Banáth J. 2004. Phosphorylation of histone H2AX as a measure of radiosensitivity. International Journal of Radiation Oncology Biology Physics 58:331-335. (Pubitemid 38142456)
29. Olive PL, Banáth JP, Keyes M. 2008. Residual gH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy. Radiotherapy and Oncology 86:336-346. (Pubitemid 351335443)
30. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Current Biology 10:886-895. (Pubitemid 30647617)
31. Pignon J, le Maître A, Maillard E, Bouhis J, on behalf of the MACH-NC Collaborative Group. 2009. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology 92:4-14.
32. Platteaux N, Dirix P, Dejaeger E, Nuyts S. 2009. Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia. Online Publication. PMID: 19711127.
33. Porcedda P,Turinetto V, Brusco A, Cavalieri S, Lantelme E, Orlando L, Ricardi U, Amoroso A, Gregori D, Giachino C. 2008. A rapid flow cytometry test based on histone H2AX phosphorylation for the sensitive and specific diagnosis of ataxia telangiectasia. Cytometry Part A 73A:508-516. (Pubitemid 351812848)
34. Rogakou EP, Boon C, Redon C, Bonner WM. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. Journal of Cell Biology 146:905-915. (Pubitemid 29430435)
35. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on Serine 139. Journal of Biological Chemistry 273:5858-5868. (Pubitemid 28124064)
36. Rosenthal DI, Lewin JS, Eisbruch A. 2006. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. Journal of Clinical Oncology 24:2636-2643. (Pubitemid 46622085)
37. Rosenthal DI, Trotti A. 2009. Strategies for managing radiationinduced mucositis in head and neck cancer. Seminars in Radiation Oncology 19:29-34.
38. Rübe CE, Grudzenski S, Kü hne M, Dong X, Rief N, Lö brich M, Rübe C. 2008. DNA double strand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model: Implications for radiosensitivity testing. Clinical Cancer Research 14:6546-6555.
39. Rübe CE, Fricke A, Schneider R, Simon K, Kü hne M, Fleckenstein J, Gräber S, Graf N, Rübe C. 2010. DNA repair alterations in children with pediatric malignancies: Novel opportunities to identify patients at risk for high-grade toxicities. International Journal of Radiation Oncology Biology Physics. (In press).
40. Stucki M, Jackson SP. 2006. gH2AX and MDC1: Anchoring the DNA-damage response machinery to broken chromosomes. DNA Repair 5:534-543.
41. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. 2002. Quantitative detection of 125IdU-induced DNA double-strand breaks with gH2AX antibody. Radiation Research 158:486-492.
42. Sonis ST. 2004. The pathobioloby of cancer. Nature Reviews Cancer 4:277-284.
43. Takahashi A, Ohnishi T. 2005. Does gH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Letters 229:171-179. (Pubitemid 41429356)
44. Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ, Weichselbaum RR. 2004. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. Journal of Biological Chemistry 279:2273-2280. (Pubitemid 38084500)
45. Turesson I, Nyman J, Holmberg E, Oden A. 1996. Prognostic factors for acute and late skin reactions in radiotherapy patients. International Journal of Radiation Oncology Biology Physics 36:1065-1075. (Pubitemid 27014492)
46. Vasireddy RS, Sprung CN, Cempaka NL, Chao M, McKay MJ. 2010. H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand bread repair cellular phenotype. British Journal of Cancer 102:1511-1518.
47. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. 2008. Evidence behind use of intensitymodulated radiotherapy: A systematic review of comparative clinical studies. Lancet Oncology 9:367-375. (Pubitemid 351411653)
48. Weissberg JB, Huang D, Swift M. 1998. Radiosensitivity of normal tissues in ataxia telangiectasia heterozygotes. International Journal of Radiation Oncology Biology Physics 42:1133-1136. (Pubitemid 29004159)
49. Werbrouck J, De Ruyck K, Beels L, Vral A, Van Eijkeren M, De Neve W, Thierens H. 2010. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: Potential of the g-H2AX foci assay and association with chromosomal radiosensitivity. Oncology Reports 23:571-578.
50. Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, van Eijkeren M, Boterberg T, Willems P, Vral A, De Neve W, Thierens H. 2009. Acute normal tissue reactions in head-and neck cancer patients treated with IMRT: Influence of dose and association with genetic polymorphisms in DNA DSB repair genes. International Journal of Radiation Oncology Biology Physics 73:1187-1195.